What's New
-
The Benefit of Personalized Medicine in Mental Health Treatment
As science evolves, we are seeing a rise in personalized or precision medicine. Personalized medicine allows an individual to have a treatment plan... -
Pharmacogenetic testing uses DNA to predict patients’ responses to medications
Article previously posted on The Globe and Mail For many Canadians, finding the right medication is a long, and often frustrating, process of tria... -
Showcasing the real-life impact of pharmacogenetic testing on the lives of those living with pain and mental health conditions
Meet "Richard" “Richard” is one of the six million Canadians with a story to tell about living with chronic pain and the impact on his mental he... -
The Healthy Helix Episode 5 Dives Into Post-Pandemic Health Trends
Inagene CEO Nancy White is joined by Jane Sarasohn-Kahn to discuss post-pandemic health trends including health economics, the echo-pandemic and technologies that are shaping a holistic approach to care. -
A partnership in innovation: Calian Group and Inagene Diagnostics partner to change the lives of Canadians suffering from mental health and pain conditions.
Calian Group Ltd., one of Canada's largest national health services organizations, supported a ground-breaking pilot study by Inagene Diagnostics in late 2020 to evaluate the “real-life” value of pharmacogenetic testing in optimizing the treatment of chronic pain and mental health conditions. Fifty Canadians who were being treated for chronic pain and concurrent mental health conditions were recruited from a busy clinic in PEI for the study in late 2020 to evaluate the impact pharmacogenetic testing could have on treatment, and on the time and cost burden involved in trialing different medications. The results were compelling and validated outcomes from previous studies.
-
Inagene Pharmacogenetic Testing Featured on Global News
On May 13th, Global News Health Matters segment featured Inagene and Pharmacogenetic testing (PGx), helping to bring awareness to how this new science is revolutionizing the way drugs are prescribed, and empowering Canadians living with mental health conditions to move beyond the antiquated “trial and error” method of finding the right treatment and start feeling better, sooner. -
Inagene Diagnostics Inc. and dnaPower release Episode 4 of The Healthy Helix: Innovative Tools Supporting Mental Health Management
Inagene and dnaPower Launch the fourth Episode of The Healthy Helix; a series supporting education, innovation and information across the healthcare landscape. -
Inagene Diagnostics Raises Awareness About Personalized Pain Management For All Canadians
Inagene Diagnostics raising awareness about the power of personalized pain management for all Canadians as featured on MONTRÉAL enSANTÉ magazine. -
Now available on-demand: Pharmacogenomics and Personalized Medicine – The Future is Here – Pharmacy U Conference Webinar sponsored by Inagene Diagnostics
Inagene sponsors an accredited webinar with expert pharmacist John Papastergious at the Pharmacy U Vancouver Conference this past November. -
Inagene Diagnostics Launches the Third Episode of the HealthyHelix
Inagene Diagnostics, in partnership with dnaPower, explores health through the lens of genetics, personalized medicine and prevention to help individuals make the best decisions to live their healthiest lives in the context of COVID-19. -
Inagene launches NEW Personalized Insights™ PrecisionRx: the “other test” that can help protect your health
A powerful tool for those looking to do more to protect their health in the event they are hospitalized for COVID 19 (or any other medical condition). -
Inagene Diagnostics Launches the Second Episode of the HealthyHelix
Inagene Diagnostics in partnership with dnaPower, take a dive deep to inform consumers how their test results can be transformative in achieving their best health
- Page 1 of 2
- Next page